The DMD patients with poorest prognosis who lost ambulation before ten years of age included in this study showed an increase in VLA-4 expression on T cells and a higher expression of the interstitial VLA-4 ligand, fibronectin, within the muscle. This evidence concerns the gene FN1 and Duchenne muscular dystrophy.